Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China flag China · Delayed Price · Currency is CNY
4.320
+0.060 (1.41%)
Nov 17, 2026, 3:00 PM CST

SHA:600866 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
19.67978.89943.15677.95608.33152.14
Depreciation & Amortization
845.48845.48846.3853.54982.19103.83
Other Amortization
8.858.851.891.511.020.6
Loss (Gain) From Sale of Assets
5.295.29-28.69-0.3-4.35-0.83
Asset Writedown & Restructuring Costs
13.3613.3698.81108.8529.48-0.91
Loss (Gain) From Sale of Investments
-27.86-27.86-4.75-13.53-7.3-6.67
Provision & Write-off of Bad Debts
9.519.51-4.565.753.23-2.86
Other Operating Activities
-539.74145.21395.81286.13893.3291.45
Change in Accounts Receivable
-40.82-40.82314.5582.68296.4112.79
Change in Inventory
-208.76-208.76228.011,056-878.41-5.99
Change in Accounts Payable
-430.77-430.77-371.31-1,020-243.24-260.78
Operating Cash Flow
-352.161,2922,3982,0261,663168.2
Operating Cash Flow Growth
--46.12%18.34%21.87%888.42%-32.72%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,961-2,039-638.5-375.83-452.34-349.79
Sale of Property, Plant & Equipment
1.463.229.50.1913.3723.48
Divestitures
-----20.08
Investment in Securities
-402.28-390.58-238.81-491.86-350-11.09
Other Investing Activities
506.2116.683.668.710.412.89
Investing Cash Flow
-1,856-2,409-864.15-858.79-788.57-314.44

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2,891----
Long-Term Debt Issued
-2,1503,1353,7064,9181,554
Total Debt Issued
5,3245,0413,1353,7064,9181,554
Long-Term Debt Repaid
--3,975-4,104-4,275-5,108-1,181
Lease Payments
-4.23-4.23-18.82---
Net Debt Issued (Repaid)
1,8111,066-969.38-569.23-189.84373.41
Issuance of Common Stock
49.5887.7961.6550--
Common Dividends Paid
-729.07-726.54-744.67-152.22-367.51-90.72
Other Financing Activities
235.35872.45-45.68-30.26-49.2-133.79
Financing Cash Flow
1,3661,300-1,698-701.71-606.54148.9

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-55.19-14.0429.47-0.74-66.915.55
Net Cash Flow
-896.92168.75-135.01464.86200.488.22

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,314-746.521,7591,6501,210-181.59
Free Cash Flow Growth
--6.60%36.37%--
Free Cash Flow Margin
-14.34%-4.70%10.15%9.50%6.92%-4.46%
Free Cash Flow Per Share
-1.39-0.451.060.991.02-0.23
Levered Free Cash Flow
-1,878-1,3922,000363.03982.216.55
Unlevered Free Cash Flow
-1,823-1,3422,068471.451,13458.65
Free Cash Flow After Leases
-2,318-750.761,7401,6501,210-181.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
-66.648.93-121.12-123.99-15.41
Change in Working Capital
-686.72-686.72149.78106.2-843.4-168.55